Tyra Biosciences (TYRA) Profit After Tax (2020 - 2026)

Tyra Biosciences (TYRA) has 7 years of Profit After Tax data on file, last reported at -$39.6 million in Q1 2026.

• Quarterly Profit After Tax fell 40.66% year-over-year to -$39.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$131.4 million (down 37.65% YoY) and the FY2025 annual result came in at -$120.3 million, down 39.76% from the prior year.
• Profit After Tax slipped to -$39.6 million in Q1 2026, from -$33.9 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of -$11.9 million in Q1 2023 to a low of -$39.6 million in Q1 2026.
• A 5-year average of -$21.7 million and a median of -$21.2 million in 2023 frame the typical range for Profit After Tax.
• Annual changes were most pronounced in 2022 — Profit After Tax tumbled 252.25% — and 2023, when it climbed 19.87%.
• Tracing TYRA's Profit After Tax over 5 years: stood at -$12.9 million in 2022, then plunged by 74.09% to -$22.4 million in 2023, then decreased by 18.28% to -$26.6 million in 2024, then fell by 27.61% to -$33.9 million in 2025, then retreated by 16.85% to -$39.6 million in 2026.
• The last three Profit After Tax figures came in at -$39.6 million (Q1 2026), -$33.9 million (Q4 2025), and -$29.9 million (Q3 2025), per Business Quant data.